These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8672726)

  • 21. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.
    Addo MM; Altfeld M; Rosenberg ES; Eldridge RL; Philips MN; Habeeb K; Khatri A; Brander C; Robbins GK; Mazzara GP; Goulder PJ; Walker BD;
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1781-6. PubMed ID: 11172028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Tat modulates T-bet expression and induces Th1 type of immune response.
    Kulkarni A; Ravi DS; Singh K; Rampalli S; Parekh V; Mitra D; Chattopadhyay S
    Biochem Biophys Res Commun; 2005 Apr; 329(2):706-12. PubMed ID: 15737643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors.
    Patki AH; Lederman MM
    Cell Immunol; 1996 Apr; 169(1):40-6. PubMed ID: 8612292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of viral replication and disease onset in cynomolgus monkeys by HIV-1 TAT vaccine.
    Ensoli B; Cafaro A
    J Biol Regul Homeost Agents; 2000; 14(1):22-6. PubMed ID: 10763887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoids rescue CD4+ T lymphocytes from activation-induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy.
    Lu W; Salerno-Goncalves R; Yuan J; Sylvie D; Han DS; Andrieu JM
    AIDS; 1995 Jan; 9(1):35-42. PubMed ID: 7893439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical mechanisms of HIV induced T cell apoptosis.
    Selliah N; Finkel TH
    Cell Death Differ; 2001 Feb; 8(2):127-36. PubMed ID: 11313714
    [No Abstract]   [Full Text] [Related]  

  • 29. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
    J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection.
    Huigen MC; Kamp W; Nottet HS
    Eur J Clin Invest; 2004 Jan; 34(1):57-66. PubMed ID: 14984439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients.
    Rossi C; Balboni PG; Betti M; Marconi PC; Bozzini R; Grossi MP; Barbanti-Brodano G; Caputo A
    Gene Ther; 1997 Nov; 4(11):1261-9. PubMed ID: 9425451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV type 1 Tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals.
    Katsikis PD; García-Ojeda ME; Torres-Roca JF; Greenwald DR; Herzenberg LA; Herzenberg LA
    Int Immunol; 1997 Jun; 9(6):835-41. PubMed ID: 9199966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viro-immunological studies in acute HIV-1 infection.
    Roos MT; de Leeuw NA; Claessen FA; Huisman HG; Kootstra NA; Meyaard L; Schellekens PT; Schuitemaker H; Miedema F
    AIDS; 1994 Nov; 8(11):1533-8. PubMed ID: 7848590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocytes deliver Tat to interferon-gamma-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro.
    Corinti S; Chiarantini L; Dominici S; Laguardia ME; Magnani M; Girolomoni G
    J Leukoc Biol; 2002 Apr; 71(4):652-8. PubMed ID: 11927652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.
    Rodriguez B; Lederman MM; Jiang W; Bazdar DA; Gàrate K; Harding CV; Sieg SF
    AIDS; 2006 Jun; 20(10):1379-89. PubMed ID: 16791012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenic properties of human immunodeficiency virus type 1 Tat protein.
    Albini A; Barillari G; Benelli R; Gallo RC; Ensoli B
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4838-42. PubMed ID: 7539135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.
    Bam RA; Hansen D; Irrinki A; Mulato A; Jones GS; Hesselgesser J; Frey CR; Cihlar T; Yant SR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.
    Buseyne F; Scott-Algara D; Porrot F; Corre B; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
    J Virol; 2002 Dec; 76(24):12414-22. PubMed ID: 12438567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-10 inhibits HIV-1 replication and is induced by tat.
    Masood R; Lunardi-Iskandar Y; Moudgil T; Zhang Y; Law RE; Huang CL; Puri RK; Levine AM; Gill PS
    Biochem Biophys Res Commun; 1994 Jul; 202(1):374-83. PubMed ID: 8037735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
    Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
    Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.